Works about PEPTIDE vaccines

Results: 241
    1
    2
    3
    4
    5
    6
    7
    8
    9

    TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-60281-8
    By:
    • Emmers, Mitchell;
    • Welters, Marij J. P.;
    • Dietz, Michelle V.;
    • Santegoets, Saskia J.;
    • Boekesteijn, Sanne;
    • Stolk, Anouk;
    • Loof, Nikki M.;
    • Dumoulin, Daphne W.;
    • Geel, Annemarie L.;
    • Steinbusch, Lauri C.;
    • Valentijn, A. Rob P. M.;
    • Cohen, Danielle;
    • de Miranda, Noel F. C. C.;
    • Smit, Egbert F.;
    • Gelderblom, Hans;
    • van Hall, Thorbald;
    • Aerts, Joachim G.;
    • van der Burg, Sjoerd H.
    Publication type:
    Article
    10

    Development of bivalent RBD adapted COVID-19 vaccines for broad sarbecovirus immunity.

    Published in:
    NPJ Vaccines, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41541-025-01156-3
    By:
    • Bruno, Laura A.;
    • Pueblas Castro, Celeste;
    • Demaría, Agostina;
    • Prado, Lineia;
    • Fascetto Cassero, Clara G.;
    • Saposnik, Lucas M.;
    • Páez Córdoba, Federico;
    • Rodriguez, Juan Manuel;
    • Piccini, Giulia;
    • Antonelli, Roberta;
    • Lapini, Giulia;
    • Temperton, Nigel;
    • Del Priore, Sabrina A.;
    • Hernando Insua, Andres C.;
    • Kaufmann, Ingrid G.;
    • Vega, Julio C.;
    • Flo, Juan M.;
    • Pasquevich, Karina A.;
    • Coria, Lorena M.;
    • Cassataro, Juliana
    Publication type:
    Article
    11

    A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9.

    Published in:
    European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1473, doi. 10.1007/s00228-021-03149-2
    By:
    • Zeitlinger, Markus;
    • Bauer, Martin;
    • Reindl-Schwaighofer, Roman;
    • Stoekenbroek, Robert M.;
    • Lambert, Gilles;
    • Berger-Sieczkowski, Evelyn;
    • Lagler, Heimo;
    • Oesterreicher, Zoe;
    • Wulkersdorfer, Beatrix;
    • Lührs, Petra;
    • Galabova, Gergana;
    • Schwenke, Carsten;
    • Mader, Robert M.;
    • Medori, Rossella;
    • Landlinger, Christine;
    • Kutzelnigg, Alexandra;
    • Staffler, Günther
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Nucleic acid‐based vaccine for ovarian cancer cells; bench to bedside.

    Published in:
    Cell Biochemistry & Function, 2024, v. 42, n. 2, p. 1, doi. 10.1002/cbf.3978
    By:
    • Al‐Hawary, Sulieman Ibraheem Shelash;
    • Jasim, Saade Abdalkareem;
    • Hjazi, Ahmed;
    • Oghenemaro, Enwa Felix;
    • Kaur, Irwanjot;
    • Kumar, Abhinav;
    • Al‐Ani, Ahmed Muzahem;
    • Alwaily, Enas R.;
    • Redhee, Ahmed Huseen;
    • Mustafa, Yasser Fakri
    Publication type:
    Article
    48
    49
    50